drugset
drugset / Trial / NCT05999474

Combined Fractional CO2 Laser With Topical Tioconazole Versus Q-switched Nd:YAG Laser in the Treatment of Onychomycosis; a Randomized Controlled Trial

NCT05999474 ↗

Phase 4 Unknown 30 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

Our aim is to assess the clinical efficacy and the safety of fractional CO2 laser combined with topical tioconazole versus Q-switched Nd:YAG laser in the treatment of OM.

Timeline

Start
2022-09-01
Primary completion
2023-09-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject tioconazole Small molecule 28 % Topical

Indications

tinea unguium